There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
A sensitive and reliable chemiluminescence immunoassay suitable for the quantitative
determination of prostaglandin E2 (PGE2) has been developed using 96 well microtiter
plates (MTP). The assay is based on a competitive reaction between a highly specific
monoclonal anti-PGE2 antibody (mouse), free antigen and solid phase bound antigen.
The MTP was first coated with a bovine serum albumin (BSA)-PGE2 conjugate. Then, after
preincubating, the anti-PGE2 antibody (Ab) and the analyte were added. The remaining
amount of free antibody was captured by the solid phase bound BSA-PGE2 conjugate.
The monoclonal antibody captured on the MTP was determined using biotinylated anti-mouse-Ab
and a complex of avidin and biotin-labelled horseradish peroxidase (HRP). Substrate
for HRP was the cyclic diacyl hydrazide compound luminol, enhanced by p-iodophenol.
Photons emitted during the reaction were measured using a photomultiplier tube. The
assay has been validated with assay buffer and human plasma over a concentration range
of 10-50,000 pg/ml. The lower limit of quantification is 100 pg/ml (2 pg/well) and
150 pg/ml (3 pg/well) for buffer and plasma, respectively. The intra-day coefficients
of variation (CV) for the range of 100-50,000 pg/ml are 3.2-8.9% (buffer) and 4.2-17.7%
(plasma) and inter-day CV are 2.9-19.8% (buffer) and 3.6-21.2% (plasma). The method
can be used for quantification of PGE2 in biological fluids like plasma and suction
blister fluid.